Innovations in TAVR: The Latest in Device Technology
Open Access
- 10 July 2025
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (14) , 4906
Abstract
Aortic stenosis is the most prevalent valvular disease globally. Transcatheter aortic valve replacement (TAVR) has become a well-established treatment for aortic stenosis, offering outcomes comparable to surgical aortic valve replacement (SAVR). Its use has expanded to include younger, lower-risk patients and those with more complex anatomies. Recent advancements in TAVR include the increased adoption of transfemoral access, prosthesis designs optimized for challenging anatomies, enhanced delivery systems with repositioning capabilities, and outer skirts to minimize paravalvular leaks. Despite these innovations, several challenges remain. This review highlights recent updates in transcatheter heart valve (THV) systems, leaflet modification devices, and the current limitations of TAVR.Keywords
This publication has 35 references indexed in Scilit:
- Transcatheter Treatment of Valvular Heart DiseaseJAMA, 2021
- Non-implant valve repair for calcific aortic stenosis: the Leaflex studyEuroIntervention, 2021
- Valve-in-Valve Transcatheter Aortic Valve Replacement Versus Redo Surgical Aortic Valve ReplacementJACC: Cardiovascular Interventions, 2021
- Leaflet immobility and thrombosis in transcatheter aortic valve replacementEuropean Heart Journal, 2020
- Contemporary Presentation and Management of Valvular Heart DiseaseCirculation, 2019
- Antithrombotic Therapy in Transcatheter Aortic Valve ReplacementFrontiers in Cardiovascular Medicine, 2019
- Usefulness of Transcatheter Aortic Valve Implantation for Treatment of Pure Native Aortic Valve RegurgitationThe American Journal of Cardiology, 2018
- Computed tomography assessment for transcatheter aortic valve in valve implantation: The vancouver approach to predict anatomical risk for coronary obstruction and other considerationsJournal of Cardiovascular Computed Tomography, 2016
- The Leaflex™ Catheter System – a viable treatment option alongside valve replacement? Preclinical feasibility of a novel device designed for fracturing aortic valveEuroIntervention, 2015
- Valvular Heart DiseaseCirculation, 2005